Perk Labs Inc.
PERK.CN · CNQ
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | -0.02 | 0.11 | 0.03 |
| FCF Yield | -3.48% | -3.26% | -4.42% | -18.89% |
| EV / EBITDA | -7.75 | -9.55 | -40.57 | -3.72 |
| Quality | ||||
| ROIC | -11.95% | -12.82% | 188.76% | -202.67% |
| Gross Margin | 9.51% | 0.12% | 44.61% | 20.41% |
| Cash Conversion Ratio | 0.25 | 0.28 | 1.49 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.86% | -6.84% | -29.82% | -20.93% |
| Free Cash Flow Growth | 26.06% | 13.49% | 40.66% | -17.08% |
| Safety | ||||
| Net Debt / EBITDA | -0.66 | -0.38 | 0.23 | 0.54 |
| Interest Coverage | -6.97 | -39.91 | -53.71 | -9.48 |
| Efficiency | ||||
| Inventory Turnover | 5.27 | 23.03 | 0.88 | 5.86 |
| Cash Conversion Cycle | -8,532.67 | -1,773.67 | -14,288.26 | -1,589.90 |